Uprzejmie informujemy, iż 16 stycznia br. otwarto nabór wniosków w ramach 2. międzynarodowego konkursu organizowanego w ramach programu ERA-CVD Cardiovascular Diseases. Konkurs skupia się na finansowaniu badań obejmujących zagadnienia z zakresu chorób sercowo-naczyniowych.
Nazwa konkursu:
2nd Joint Transnational Call (JTC 2017)
Temat konkursu:
“Mechanisms of early atherosclerosis and/or plaque instability in Coronary Artery Disease”
Zakres konkursu:
The JTC 2017 aims at enabling scientists in different countries to build an effective collaboration on common multidisciplinary research projects based on complementarities and sharing of expertise in the field of coronary artery disease, with a clear translational research approach.
Supported projects are expected to have a concrete impact in the early recognition and prognosis of CAD and will be of help at identifying those individuals/patients who will likely develop acute events in the near future (0-12 months).
Transnational research proposals must cover at least one of the following two sub-topics, which are equally relevant for this call, in relation to early recognition of CAD:
- exploration of mechanisms leading to plaque instability, including the role of genetic factors, nutritional and gut microbiota giving mechanistic insights into the development, progression or plaque instability;
- improvement of imaging techniques as well as validation of biomarkers (genetic, epigenetic, lipidomic, proteomic, metabolomics, microbiota), leading to earlier recognition of risk and/or protective factors. Biomarkers are characteristics that are measured as an indicator of a biological or pathological process, or of a pharmacological response. Validation studies must provide published data on the sensitivity of the biomarker in question and may apply for further specificity, bio-analytical assessment, probability of false positives or false negatives and Pharmacokinetic-Pharmacodynamic (PK-PD) model validation steps.
Additionally, each proposal should consider the following cross-sectional aspects:
- interdisciplinary approach, e.g. integrating biomedicine, physics, chemistry, mathematics, systems biology and clinical medicine for the development of the applications;
- research on sex/gender differences in order to give further mechanistic insights into the development of the disease, its progression and to identify difference in treatment responses;
- Translational research approach/perspective.
Data otwarcia naboru wniosków:
16 stycznia 2017 r.
Data zamknięcia naboru wniosków:
6 marzec 2017 r.
Budżet NCBR
Na dofinansowanie udziału polskich podmiotów w projektach wyłonionych w ramach konkursu NCBR przeznaczyło budżet w wysokości 500 000 euro.
Koszt projektu polskiego partnera nie powinien przekraczać 200 000 euro.
Więcej informacji na stronie intenetowej: http://www.ncbr.gov.pl/programy-miedzynarodowe/era-net-co-fund/era-cvd/aktualnosci/art,4854,otwarcie-naboru-wnioskow-w-2-konkursie-w-ramach-era-cvd-cardiovascular-diseases.html
